Replimune Group, Inc. (REPL:NASDAQ) closed at $21.89 on November 13, 2026, down 0.41% on the day. The stock trades 7.0% below its 52-week high of $23.54 and 1,359.3% above its 52-week low of $1.50. Over the past year, it gained 143.5%. Replimune Group, Inc. is part of the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)).
In 252 trading sessions since November 13, 2025, REPL closed higher on 119 days (47%). Its best day was July 31, 2026 (+107.02%) and its worst was April 13, 2026 (-64.29%). The stock moved 10% or more in a single session 28 times. It opened at least 5% above the previous day's high 3 times.
Replimune Group Inc is a clinical-stage biotechnology company. Its use proprietary Immulytic platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The company's pipeline products include RP1, RP2, and RP3.
Find more stocks like REPL with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.